statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Shockwave Medical, Inc. (NasdaqGS: SWAV) to...

SHOCKWAVE MEDICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Shockwave Medical, Inc. - SWAV

Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036 Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion...

Fight Against Pancreatic Cancer Ramps Up as Market Size Revenues Expected to Exceed $36 Billion by 2036

A Deep Dive Into The Opioid Crisis

 Authored by Matt Bivens, M.D. via Racket News,

Editor's note: the following is the first essay in a series, written by former Moscow Times co-worker...

A Deep Dive Into The Opioid Crisis

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 45th Annual Global Healthcare Conference on Wednesday, June 12th, at the Loews Miami Beach Hotel, Miami Beach, Florida. Jennifer...

Johnson & Johnson to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference

Investopedia

 Key TakeawaysThe S&P 500 ticked 0.1% higher on Tuesday, May 7, 2024, holding on to its streak of winning sessions dating back to the middle of last week.Shares of FMC Corp. soared...

S&P 500 Gains and Losses Today: Builders FirstSource Falls Amid Lower Margins

Johnson & Johnson unveils promising TARIS platform data for bladder cancer treatment, highlighting ease of administration and significant revenue potential.

 Latest Ratings for JNJ...

Johnson & Johnson's TARIS Platform - Goldman Sachs Outlines Potential For The Bladder Cancer Therapy

NurPhoto / Contributor / Getty Images

 Key TakeawaysU.S. equities rose at midday Tuesday, May 7, 2024 following the latest earnings news and ahead of more data that could impact the Federal...

Top Stock Movers Now: Walt Disney, Datadog, Ferrari, and More

Time To Buy Johnson & Johnson? One Analyst Sees The Stock's Price Gaining Over 40...

Time To Buy Johnson & Johnson? One Analyst Sees The Stock's Price Gaining Over 40%

Ex-CNN Host Chris Cuomo Reveals COVID Vaccine Injury: "I'm Sick Myself"

 Authored by Jack Phillips via The Epoch Times (emphasis ours),

Former CNN host Chris Cuomo said in a recent news...

Ex-CNN Host Chris Cuomo Reveals COVID Vaccine Injury: "I'm Sick Myself"

Johnson & Johnson's results in treating bladder and prostate cancer. Learn about TAR-210's efficacy in high-risk NMIBC patients and TAR-200's promising outcomes for BCG-unresponsive cases.
read more...

Johnson & Johnson Advances Its Two Bladder Cancer Studies, Releases Latest Data

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Watchers	45,480
52-Wk Low	$143.13
52-Wk High	$175.97

Volume	15,758.00
52-Wk High	$175.97
52-Wk Low	$143.13

JNJ Johnson & Johnson

About

Feed

News

Sentiment

Earnings

Fundamentals